Assisted Reproduction Registries and Reporting
RRM Academy Synopsis
Australian ART Registry Success Varied by Women's Age in 2004
Australia and New Zealand's 2004 national ART registry tracked 41,904 fertility treatment cycles across the two countries. As women's age at treatment rose, non-donor fresh cycle success ranged from 34 in 100 down to just 7 in 100. Across all cycle types that year, about 16 out of 100 cycles ended in a live birth.
Key Findings
- In 2004, 41,904 ART treatment cycles started in Australia and New Zealand: 38,823 (92.6%) in Australia and 3,081 (7.4%) in New Zealand.
- For non-donor fresh cycles with oocyte retrieval, 33.5% led to a live delivery for women aged 23 to 24, versus 7.1% for women aged 40 to 44.
- Of all 41,904 cycles started that year, 8,794 resulted in a clinical pregnancy and 6,792 ended in a live delivery, 16.2% of cycles started.
- Twin gestation deliveries occurred in 16.1% (1,114) of cycles ending in delivery. Preterm birth affected 25.2% of babies born after 2004 ART treatment: 10.9% of singletons, 59.9% of twins.
- The perinatal mortality rate was 19.3 deaths per 1,000 births overall: 16.0 for singletons and 26.9 for twins.
Interpretation
This is a national registry report. The report counts ART cycles done at fertility centers in Australia and New Zealand in 2004. There is no comparison group. Success is measured per cycle. The per-cycle measure does not reflect a woman's whole course of treatment. So the age-related decline reflects outcomes within that one year. Perinatal death counts come from reports to centers. The registry does not treat these as official vital statistics. The report itself cautions that small numbers make these rates imprecise. The multiple-birth figures show twins had higher rates of preterm birth, low birthweight and death than singleton births.
RRM Context
This report documents ART outcomes. ART bypasses the reason a couple has not conceived. ART does not diagnose or treat that reason. Restorative reproductive medicine instead works to find and treat the underlying cause of infertility. The same report found male factor infertility, alone or combined with other causes, reported in 40.9% of ART treatment cycles in 2004. The registry's own figures on twin pregnancies, preterm birth and perinatal death show risks tied to multiple-embryo transfer, a practice many ART programs have since moved away from.
Key figures
Treatment activity, 2004
| Measure | Value | Source |
|---|---|---|
| Total ART treatment cycles undertaken in Australia and New Zealand, 2004 | 41,904 | Report text |
| Cancelled cycles included within the 2004 total ART treatment cycle count | 2,425 | Report text |
| Share of all ART treatment cycles undertaken in Australia, 2004 | 92.6% | Report text |
| Share of all ART treatment cycles undertaken in New Zealand, 2004 | 7.4% | Report text |
| ART cycles per 1,000 women aged 15-44, Australia, 2004 | 9.0 | Report text |
| ART cycles per 1,000 women aged 15-44, New Zealand, 2004 | 3.5 | Report text |
| Non-donor ART treatment cycles undertaken, 2004 | 39,212 | Report text |
| Fresh cycles as a share of non-donor ART cycles, 2004 | 57.2% | Report text |
| Thaw and mixed fresh-thaw cycles as a share of non-donor ART cycles, 2004 | 36.6% | Report text |
Patient characteristics, 2004
| Measure | Value | Source |
|---|---|---|
| Average age of women who underwent ART treatment, 2004 | 35.4 | Table 6 |
Pregnancy and birth outcomes, 2004
| Measure | Value | Source |
|---|---|---|
| Non-donor fresh cycles with oocyte retrieval that resulted in a clinical pregnancy, 2004 | 25.8% | Table 10 |
| Non-donor fresh cycles with oocyte/embryo transfer that resulted in a clinical pregnancy, 2004 | 29.3% | Table 10 |
| Non-donor fresh cycles with oocyte retrieval that resulted in a live delivery, 2004 | 20.1% | Table 10 |
| Non-donor fresh cycles with oocyte/embryo transfer that resulted in a live delivery, 2004 | 22.8% | Table 10 |
Embryo transfer practice, 2004
| Measure | Value | Source |
|---|---|---|
| Embryo transfer cycles in which one or two embryos were used, 2004 | 96.8% | Table 4 |
| Embryo transfer cycles in which one or two embryos were used (2002, for comparison) | 94.0% | Table 4 |
| Embryo transfer cycles in which one or two embryos were used (2003, for comparison) | 95.7% | Table 4 |
Multiple births, 2004
| Measure | Value | Source |
|---|---|---|
| Total ART deliveries, 2004 | 6,932 | Table 25 |
| ART deliveries that were twin or higher-order multiples, 2004 | 16.4% (1,137) | Table 25 |
| Multiple gestation deliveries among all births in Australia (2003, context, not ART's own figure) | 1.7% | Report text |
| Twin deliveries as a share of all ART deliveries, 2004 | 16.1% | Report text |
Trends, 1995 to 2004
| Measure | Value | Source |
|---|---|---|
| Triplet or higher-order multiple deliveries as a share of all ART deliveries, 1995 to 2004 | 1.9% to 0.3% | Report text |
Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.
Read the guide
-
ART Registries and Codes of Practice: A Reference for Patients and Clinicians
A global reference to national IVF registries (HFEA, RTAC, ANZARD, Q-IVF, CDC, DIR, JSOG, CARTR Plus, REDLARA, ESHRE EIM, ICMART) and the codes of practice that govern fertility clinics. What each measures, and what they miss.


